Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Rajant Health Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. The prosecution is handled by 2 distinct examiners across 2 distinct art units. This arrangement reflects a diversified review process for the company's active applications.
The busiest examiner is SMITH, JENNIFER JOY, who manages 1 pending office action. With 2 pending office actions total, the workload is distributed among the 2 distinct examiners. The use of 2 distinct art units suggests that the pending matters involve different specialized areas of pharmaceutical or biological technology.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SMITH, JENNIFER JOY | 1 | — | — |
| MUTREJA, JYOTI NAGPAUL | 1 | 81.0% | +4.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17833842 | CARTRIDGE-BASED BIOFLUID MONITORING AND ANALYSIS | MUTREJA, JYOTI NAGPAUL | 32d overdue |
| 17806477 | AI-ENABLED HEALTH PLATFORM | SMITH, JENNIFER JOY | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17806477 | AI-ENABLED HEALTH PLATFORM | SMITH, JENNIFER JOY | 1685 | §101§103 | Final Rejection | — | Pending | Jun 10, 2022 |
| 17833842 | CARTRIDGE-BASED BIOFLUID MONITORING AND ANALYSIS | MUTREJA, JYOTI NAGPAUL | 1758 | §103§112 | Non-Final OA | 32d overdue | Pending | Jun 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial